NCT06817122

Brief Summary

The goal of this research is to educate people about different technologies to support care at home when someone is experiencing memory difficulties. "Let's Talk Tech" is a new tool to educate people about technologies commonly used to support care and monitor safety, and help families talk about their feelings about them to understand each other's perspectives. The goal of this clinical trial is to learn if "Let's Talk Tech" helps people feel more prepared to make decisions about technologies. Researchers will compare Let's Talk Tech to usual care (no intervention) to see if Let's Talk Tech increases peoples' preparedness and confidence to make decisions about technologies. Participants will:

  • Use the Let's Talk Tech web application together with their study partner that takes up to an hour or do nothing.
  • Complete three surveys. The second survey will be taken within 2 weeks of the first and the last survey will be taken 3 months after the first.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

February 7, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 25, 2025

Status Verified

February 1, 2025

Enrollment Period

1.1 years

First QC Date

January 3, 2025

Last Update Submit

March 24, 2025

Conditions

Keywords

Let's Talk Techshared decision aidtechnology decision makingadvance care planningdyadic intervention

Outcome Measures

Primary Outcomes (8)

  • Preparedness to make technology decisions

    Participant rates on a 5-point Likert scale \[1="Strongly agree" to 5="Strongly disagree"\] how much they agree with the statement that they feel prepared to make decisions about technology use for their study partner.

    baseline, 2-week post-test and 3 months

  • Decisional Conflict Scale

    The Decisional Conflict Scale is a 16-item scale with 5 response categories \[0= "Strongly agree" to 4="Strongly disagree"\]. Higher scores reflect higher decisional conflict in decision making.

    baseline, 2-week post-test and 3 months

  • Technology awareness

    Participant rates on a 5-point Likert scale \[1="Very aware" to 5="Very unaware"\] how aware they are about technologies available to support their partner's care and safety.

    baseline and 2-week post-test

  • Technology understanding

    4 items assess perceived understanding of each of 4 technologies featured in the intervention \[1="Not at all" to 5="Completely"\].

    baseline and 2-week post-test

  • Perception of PLWD/MCI's technology understanding

    4 items assess care partner's perception of how well their study partner understands of each of 4 technologies featured in the intervention \[1="Not at all" to 5="Completely"\].

    baseline and 2-week post-test

  • Satisfaction with dyadic communication about technology

    Participant rates on a 5-point Likert scale \[1="Very satisfied" to 5="Very dissatisfied"\] how satisfied they are with their discussion with their study partner about using technology to support their care or safety.

    baseline and 2-week post-test

  • Intention to honor preferences

    Participant rates on a 5-point Likert scale \[1="Very likely" to 5="Very unlikely"\] how likely they are to honor their partner's preferences for how technology is used in their care.

    baseline and 2-week post-test

  • Dyadic alignment about technology use

    Participant is asked how much they agree with their partner about using technologies to support their care \[1="Not at all" to 5="Completely"\].

    baseline and 2-week post-test

Secondary Outcomes (2)

  • Shared technology preferences

    baseline, 2-week post-test and 3 months

  • Confidence preferences will be honored

    baseline, 2-week post-test and 3 months

Study Arms (2)

Let's Talk Tech intervention

EXPERIMENTAL

The intervention group will complete the single use self-administered Let's Talk Tech intervention together as a dyad.

Behavioral: Let's Talk Tech

Usual care

NO INTERVENTION

This control group will receive usual care, which means they will complete no intervention.

Interventions

Let's Talk TechBEHAVIORAL

Let's Talk Tech is a self-administered dyadic education and communication tool delivered as a web application to support shared decision making about technology use.

Let's Talk Tech intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have mild cognitive impairment (MCI) or mild dementia
  • age 55 or older
  • able to understand and speak English
  • be identified by the patient as their primary support person
  • age 18 or older
  • able to understand and speak English
  • able to complete LTT together with their study partner at the same time

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98105, United States

RECRUITING

MeSH Terms

Conditions

DementiaLymphoma, FollicularCognitive Dysfunction

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesCognition Disorders

Study Officials

  • Clara Berridge, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clara Berridge, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor: School of Social Work

Study Record Dates

First Submitted

January 3, 2025

First Posted

February 10, 2025

Study Start

February 7, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

March 25, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations